Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First-line systemic therapy in patients with metastatic castration-sensitive prostate cancer should be based on individual disease and patient characteristics, results of a meta-analysis suggest.
In a subset of patients with high-risk prostate cancer, the combination of abiraterone acetate plus prednisone (AAP) and apalutamide may improve outcomes when added to salvage radiation therapy.
Members of Congress are pushing to test whether costs of certain US drugs could be lowered by using the Bayh-Dole "march-in" provision on patent rights regarding discoveries supported by federal money.
The widespread use of aggressive care at the end of life for nursing home residents with metastatic cancer suggests the increased emphasis on less intensive care is not getting through, suggests US research.
Big data and artificial intelligence could lead the way in future cancer research and clinical care.